Europe • Frankfurt Stock Exchange • FRA:1SXP • DE000A3ENQ51
The current stock price of 1SXP.DE is 14.2 EUR. In the past month the price decreased by -7.91%. In the past year, price decreased by -40.98%.
ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. While 1SXP.DE has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.97. The EPS decreased by -2.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.85% | ||
| ROA | 9.16% | ||
| ROE | 16.42% | ||
| Debt/Equity | 0.09 |
19 analysts have analysed 1SXP.DE and the average price target is 20.16 EUR. This implies a price increase of 41.95% is expected in the next year compared to the current price of 14.2.
For the next year, analysts expect an EPS growth of 2.98% and a revenue growth 4.39% for 1SXP.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRT3 | SARTORIUS AG-VORZUG | 39.65 | 17.964B | ||
| 56S1 | SARTORIUS STEDIM BIOTECH | 33.95 | 17.631B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 33.34 | 17.315B | ||
| SRT | SARTORIUS AG | 30.87 | 13.988B | ||
| QIA | QIAGEN N.V. | 18.9 | 9.361B | ||
| EVT | EVOTEC SE | N/A | 2.183B | ||
| GXI | GERRESHEIMER AG | 8.56 | 886.296M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 14.88 | 230.527M | ||
| MLC | MALIN CORP PLC | N/A |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
SCHOTT PHARMA AG& CO KGAA
Hattenbergstrasse 10
MAINZ HESSEN DE
Employees: 4775
Phone: 496131660
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
The current stock price of 1SXP.DE is 14.2 EUR. The price increased by 0.85% in the last trading session.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 1.28%. The yearly dividend amount is currently 0.16.
1SXP.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1SXP.DE.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) currently has 4775 employees.